IMPORTANT NOTICE: Our email addresses will soon change. Learn more >>
 
BioLegend Homepage Banner
Unpacking the Genetic Contribution of Glia to Parkinson’s Disease
Despite extensive efforts, there are no known disease-modifying therapies for Parkinson’s disease. Hear from Dr. Abby Olsen as she describes her work identifying novel glial cells and potential downstream therapeutic targets using an innovative Drosophila model to perform genetic screens.
Image of Abby Olsen, M.D., Ph.D.
Unpacking the Genetic Contribution of Glia to Parkinson’s Disease
Speaker: Abby Olsen, M.D., Ph.D.
Brigham and Women’s Hospital
Harvard Medical School

September 17, 2020
9 AM PDT/12 PM EDT
Register Now
 
ProductsHere

Login/Register
Remember me
Forgot your password? Reset Password
Request an Account